Correction: The novel TP53 3'-end methylation pattern associated with its expression would be a potential biomarker for breast cancer detection.

Zeng, Feng; Heng, Jianfu; Guo, Xinwu; Wang, Yue; Wu, Wenhan; Tang, Lili; Chen, Min; Wang, Shouman; Deng, Hongyu; Wang, Jun.

Afiliação

Zeng F; Department of Emergency, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Heng J; Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, 410013, China.
Guo X; School of Life Sciences, Central South University, Changsha, 410013, Hunan, China.
Wang Y; Sansure Biotech Inc., Changsha, 410205, Hunan, China.
Wu W; School of Life Sciences, Central South University, Changsha, 410013, Hunan, China.
Tang L; School of Life Sciences, Central South University, Changsha, 410013, Hunan, China.
Chen M; Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Wang S; Sansure Biotech Inc., Changsha, 410205, Hunan, China.
Deng H; Department of Breast Surgery, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Wang J; Hunan Cancer Hospital, Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, 410013, China.

Breast Cancer Res Treat ; 208(2): 469, 2024 Nov.

Article em En | MEDLINE | ID: mdl-39115724

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article